Correlation Between Tarsus Pharmaceuticals and GMS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and GMS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and GMS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and GMS Inc, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and GMS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of GMS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and GMS.

Diversification Opportunities for Tarsus Pharmaceuticals and GMS

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Tarsus and GMS is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and GMS Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GMS Inc and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with GMS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GMS Inc has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and GMS go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and GMS

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 2.07 times more return on investment than GMS. However, Tarsus Pharmaceuticals is 2.07 times more volatile than GMS Inc. It trades about 0.08 of its potential returns per unit of risk. GMS Inc is currently generating about 0.08 per unit of risk. If you would invest  1,548  in Tarsus Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  3,536  from holding Tarsus Pharmaceuticals or generate 228.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  GMS Inc

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
GMS Inc 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in GMS Inc are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, GMS unveiled solid returns over the last few months and may actually be approaching a breakup point.

Tarsus Pharmaceuticals and GMS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and GMS

The main advantage of trading using opposite Tarsus Pharmaceuticals and GMS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, GMS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GMS will offset losses from the drop in GMS's long position.
The idea behind Tarsus Pharmaceuticals and GMS Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals